MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-33-0090497
Clementia Pharmaceuticals Private Limited - pharma in Thane, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2026
₹2.12 Cr
▲ 5% YoY
Net profit · FY 2026
₹5.66 Lakh
Net margin 2.7%
EBITDA · FY 2026
₹20.79 Lakh
EBITDA margin 9.8%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
14 yrs
Est. 2012
Employees · EPFO
19
Provident fund records
Directors on board
3
As per MCA filings
About Clementia Pharmaceuticals Private Limited
Data last updated:
Clementia Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 July 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24290MH2012PTC233594. Its GSTIN is 27AAECC9128L1ZA (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Milind S Tawade and Sudeepto Deepak Nag.
Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Gami Industrial Park, Thane, Maharashtra.
As per the financials filed for FY 2026, the company reported a revenue of ₹2.12 Cr, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹5.66 Lakh (net margin 2.7%) and EBITDA of ₹20.79 Lakh (EBITDA margin 9.8%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 10% over five years.
The company has about 19 employees on its provident fund (EPFO) records.
Clementia Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0090497). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website clementia.co.in.
Company Details of Clementia Pharmaceuticals Private Limited
CIN U24290MH2012PTC233594
Registration Number 233594
Incorporation Date 20 July 2012
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 26 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-33-0090497
Recognitions & Rankings of Clementia Pharmaceuticals
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressShop No.103 2nd Floor Plot No.C – 39A, Gami Industrial Park Pawane, Thane, Maharashtra, India – 400710
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Clementia Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Clementia Pharmaceuticals Private Limited
The main business activity of Clementia Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Clementia Pharmaceuticals Private Limited FY 2025 filings available
Clementia Pharmaceuticals Private Limited reported revenue of ₹2.12 Cr (up 5% YoY) for FY 2026.
Revenue · FY 2026
₹2.12 Cr ▲ 5%
Net profit · FY 2026
₹5.66 Lakh margin 2.7%
EBITDA · FY 2026
₹20.79 Lakh margin 9.8%
Compounded Annual Growth Rate (CAGR) of Clementia Pharmaceuticals Private Limited
Revenue CAGR growth
1 year
▲ 5%
3 years · compounded
▲ 5%
5 years · compounded
▲ 10%
EBITDA CAGR growth
1 year
▲ 13%
3 years · compounded
▲ 42%
5 years · compounded
▲ 50%
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 5% growth in the latest year. EBITDA rose 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Clementia Pharmaceuticals Private Limited
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹20.79 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹5.66 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Clementia Pharmaceuticals Private Limited
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Clementia Pharmaceuticals are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Clementia Pharmaceuticals Private Limited
Clementia Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Milind S Tawade | Director | 20 Jul 2012 | 14 Years 3 Months | Current |
| Sudeepto Deepak Nag | Director | 20 Jul 2012 | 14 Years 3 Months | Current |
| Ganesh Vitthal Shinde | Director | 20 Jul 2012 | 14 Years 3 Months | Current |
Peer Comparison of Clementia Pharmaceuticals Private Limited
Clementia Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Clementia Pharmaceuticals Private Limited this company | ₹2.12 Cr (FY 2026) | •••• | •••• | 5.0% | •••• | Thane, Maharashtra, India |
| Polytrap Pharma Private Limited | ₹2.02 Cr (FY 2024) | •••• | •••• | 61.0% | •••• | Indore, Madhya Pradesh, India |
| Drug for Life India Private Limited | ₹2.02 Cr (FY 2024) | •••• | •••• | 10.0% | •••• | Chandigarh, India |
| Planet Herbs Lifesciences Private Limited | ₹2.02 Cr (FY 2024) | •••• | •••• | -12.0% | •••• | New Delhi, Delhi, India |
| Kind Health and Hygiene Private Limited | ₹2.02 Cr (FY 2025) | •••• | •••• | -35.0% | •••• | Junnar, Maharashtra, India |
| Vivenza International Private Limited | ₹2.02 Cr (FY 2025) | •••• | •••• | 91.0% | •••• | Mumbai, Maharashtra, India |
| Vogue Pharmaceuticals Private Limited | ₹2.02 Cr (FY 2025) | •••• | •••• | -5.0% | •••• | New Delhi, Delhi, India |
| Oncomed Pharmaceuticals India Private Limited | ₹2.02 Cr (FY 2025) | •••• | •••• | -54.0% | •••• | Patna, Bihar, India |
| Additek Life Sciences Private Limited | ₹2.01 Cr (FY 2019) | •••• | •••• | 187.0% | •••• | Vadodara, Gujarat, India |
| Watrix Pharmaceuticals Private Limited | ₹2.01 Cr (FY 2022) | •••• | •••• | 29.0% | •••• | Bangalore, Karnataka, India |
| Zoetic Formulations Private Limited | ₹2.01 Cr (FY 2025) | •••• | •••• | -5.0% | •••• | Chennai, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below Clementia Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Clementia Pharmaceuticals Private Limited
Auditor information for Clementia Pharmaceuticals Private Limited provides details about the firm responsible for auditing the company's financial statements and ensuring compliance with regulatory requirements.
Ownership and Shareholding of Clementia Pharmaceuticals Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Clementia Pharmaceuticals Private Limited
Clementia Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Clementia Pharmaceuticals Private Limited
Clementia Pharmaceuticals Private Limited has a workforce of 19 employees as of Apr 07, 2024.
Employee count
19
Active EPFO establishments
1
Employee growth
11.76%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Clementia Pharmaceuticals Private Limited
Clementia Pharmaceuticals Private Limited has 4 board changes on record since 2012: 3 appointments and 1 cessation. The latest: Anjan Choudhury ceased to be Director on 09 Feb 2016.
AGM
Clementia Pharmaceuticals Private Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records.
Filing
Clementia Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Ceased
Anjan Choudhury ceased to be Director.
Appointed
Ganesh Vitthal Shinde was appointed as Director.
Appointed
Milind S Tawade was appointed as Director.
Appointed
Sudeepto Deepak Nag was appointed as Director.
Incorporation
20 Jul 2012
Clementia Pharmaceuticals Private Limited was registered on 20 Jul 2012 with Roc Mumbai Ii & aged 14 years 3 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Clementia Pharmaceuticals Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Clementia Pharmaceuticals Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Clementia Pharmaceuticals Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Clementia Pharmaceuticals Private Limited
Clementia Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECC9128L1ZA | Maharashtra | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Clementia Pharmaceuticals Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Clementia Pharmaceuticals Private Limited
Clementia Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 July 2012 (14+ years old) and is registered under CIN U24290MH2012PTC233594.
Clementia Pharmaceuticals reported revenue of ₹2.12 Cr for FY 2026 (up 5% YoY).
Clementia Pharmaceuticals has 3 current directors:
- Milind S Tawade - Director
- Sudeepto Deepak Nag - Director
- Ganesh Vitthal Shinde - Director
Clementia Pharmaceuticals reported a net profit of ₹5.66 Lakh (net margin 2.7%) and EBITDA of ₹20.79 Lakh (EBITDA margin 9.8%) for FY 2026, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Clementia Pharmaceuticals is 5% over three years and 10% over five years. In the latest year (FY 2026) revenue rose 5%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Clementia Pharmaceuticals is 27AAECC9128L1ZA, registered in Maharashtra.
The CIN (Corporate Identification Number) of Clementia Pharmaceuticals is U24290MH2012PTC233594. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Clementia Pharmaceuticals was incorporated on 20 July 2012, making it 14+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Clementia Pharmaceuticals by revenue are Polytrap Pharma Private Limited, Drug for Life India Private Limited, Planet Herbs Lifesciences Private Limited, Kind Health and Hygiene Private Limited, Vivenza International Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Anjan Choudhury ceased to be Director on 09 Feb 2016. Ganesh Vitthal Shinde was appointed as Director on 20 Jul 2012. Milind S Tawade was appointed as Director on 20 Jul 2012. Clementia Pharmaceuticals has 4 board changes on record in total.
Yes, Clementia Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-33-0090497).